Pentostatin

FDA Approved: * August 7, 2007
Pharm Company: * BEDFORD LABS
Category: Cancer

Pentostatin (or deoxycoformycin, trade name Nipent, manufactured by SuperGen) is an anticancer chemotherapeutic drug.[1] Mechanism It is classified as a purine analog, which is a type of antimetabolite. It mimics the nucleoside adenosine and thus inhibits the enzyme adenosine deaminase, interfering with the cell's ability to process DNA.[2] Cancer cells generally divide more often than healthy cells; DNA is highly involved in cell division (mitosis) and drug... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
2 Discussions

Dosage List

Pentostatin 10 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 55390-244
Labeler:
Bedford Laboratories
Pentostatin 2 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 67457-288
Labeler:
Mylan Institutional LLC

Related Brands

Drugs with the same active ingredients

Popular Topics

Pentostatin/ Cytoxin treatment

Why has there been , so to speak, no recent, say after 2010, discussion of treatment of Waldenstroms with Pentostatin/Cy...

1 REPLY